DALYMZOH Trademark

Trademark Overview

On Tuesday, January 17, 2017, a trademark application was filed for DALYMZOH with the United States Patent and Trademark Office. The USPTO has given the DALYMZOH trademark a serial number of 87303951. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 27, 2020. This trademark is owned by Novartis AG. The DALYMZOH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, namely, analgesics, anti-inflammatory drugs and antipyretics
dalymzoh

General Information

Serial Number87303951
Word MarkDALYMZOH
Filing DateTuesday, January 17, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 27, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use, namely, analgesics, anti-inflammatory drugs and antipyretics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 24, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel 4002
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Monday, July 27, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 27, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, December 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 26, 2019EXTENSION 5 GRANTED
Tuesday, December 17, 2019EXTENSION 5 FILED
Thursday, December 26, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 17, 2019TEAS EXTENSION RECEIVED
Thursday, June 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 18, 2019EXTENSION 4 GRANTED
Tuesday, June 18, 2019EXTENSION 4 FILED
Tuesday, June 18, 2019TEAS EXTENSION RECEIVED
Friday, December 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 19, 2018EXTENSION 3 GRANTED
Wednesday, December 19, 2018EXTENSION 3 FILED
Wednesday, December 19, 2018TEAS EXTENSION RECEIVED
Thursday, June 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 19, 2018EXTENSION 2 GRANTED
Tuesday, June 19, 2018EXTENSION 2 FILED
Tuesday, June 19, 2018TEAS EXTENSION RECEIVED
Tuesday, December 19, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 16, 2017EXTENSION 1 GRANTED
Saturday, December 16, 2017EXTENSION 1 FILED
Saturday, December 16, 2017TEAS EXTENSION RECEIVED
Wednesday, June 21, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 14, 2017ASSIGNED TO EXAMINER
Tuesday, January 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 20, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

dalymzoh inflammatory drugs antipyretics anti analgesics preparations human namely pharmaceutical